GMP Manufacture of IMP
At our two dedicated GMP facilities, we specialise in small-scale IMP and placebo manufacturing of early phase clinical studies from First in Human (FIH) trials to phase II.
With an emphasis on phase appropriate GMP manufacturing, we can provide just enough clinical trial materials to allow you to conduct your clinical studies quickly, without waste and unnecessary expense.
We offer a rapid and cost-effective alternative to conventional CDMOs, providing “just in time” manufacturing services which enable small batches of drug product to be made throughout the duration of a clinical trial without the need for extensive stability programmes.
